Abstract
Antioxidant potential of some β-ionyl compounds has been assessed by examining their ability to protect methyl linoleate from aerial and 2,2-azobisisobutyronitrile-induced radical-mediated oxidation. It is observed that the π- electron density of β-ionyl structure is an important factor in the antiradical activity of these compounds.
Keywords: β-Ionone, retinoids, antiradical, antioxidants, radioprotectants, peroxidation, methyl linoleate, AIBN
Letters in Organic Chemistry
Title: Antiradical Activity of β-Ionyl Compounds
Volume: 7 Issue: 4
Author(s): Anil K. Singh and Solomon B. Libsu
Affiliation:
Keywords: β-Ionone, retinoids, antiradical, antioxidants, radioprotectants, peroxidation, methyl linoleate, AIBN
Abstract: Antioxidant potential of some β-ionyl compounds has been assessed by examining their ability to protect methyl linoleate from aerial and 2,2-azobisisobutyronitrile-induced radical-mediated oxidation. It is observed that the π- electron density of β-ionyl structure is an important factor in the antiradical activity of these compounds.
Export Options
About this article
Cite this article as:
K. Singh Anil and B. Libsu Solomon, Antiradical Activity of β-Ionyl Compounds, Letters in Organic Chemistry 2010; 7 (4) . https://dx.doi.org/10.2174/157017810791130603
DOI https://dx.doi.org/10.2174/157017810791130603 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
NF-κB Down–regulation and PARP Cleavage by novel 3-α-butyryloxy-β-boswellic Acid Results in Cancer Cell Specific Apoptosis and in vivo Tumor Regression
Anti-Cancer Agents in Medicinal Chemistry Targeted Therapies in Solid Tumours: Pinpointing the Tumours Achilles Heel
Current Pharmaceutical Design Current State of Development of Genome Analysis in Livestock
Current Genomics System Models, Assays and Endpoint Parameters to Evaluate Anticancer Compounds During Preclinical Screening
Current Medicinal Chemistry Estrogen(s) and Analogs as a Non-Immunogenic Endogenous Ligand in Targeted Drug/DNA Delivery
Current Medicinal Chemistry Fluoroquinolone and Ovariectomy in the Bitch: Physiology of the Immune System as to CD56 and CD16 Expression
Endocrine, Metabolic & Immune Disorders - Drug Targets Phytoestrogens and Mitochondrial Biogenesis in Breast Cancer. Influence of Estrogen Receptors Ratio
Current Pharmaceutical Design Investigations of Malignant Mesothelioma
Current Respiratory Medicine Reviews Selenium and Colon Cancer – From Chemoprevention to New Treatment Modality
Anti-Cancer Agents in Medicinal Chemistry Current Strategies for Modulating Lymphangiogenesis Signalling Pathways in Human Disease
Current Medicinal Chemistry Mechanism of Action and Therapeutic Potential of Novel Adamantyl Retinoid-Related Molecules
Current Cancer Therapy Reviews Nanotechnology for Delivery of Drugs and Biomedical Applications
Current Clinical Pharmacology The Role of YY1 in Oncogenesis and Its Potential as a Drug Target in Cancer Therapies
Current Cancer Drug Targets Wrap-and-Strip Technology of Protein–Polyelectrolyte Complex for Biomedical Application
Current Medicinal Chemistry Molecular Biological Roles of Ursolic Acid in the Treatment of Human Diseases
Current Bioactive Compounds Recent Patents Concerning Modulators of Protein Kinase C
Recent Patents on DNA & Gene Sequences Small-molecule Modulation of HDAC6 Activity: The Propitious Therapeutic Strategy to Vanquish Neurodegenerative Disorders
Current Medicinal Chemistry Molecular Mechanisms and Targeted Therapies Including Immunotherapy for Non-Small Cell Lung Cancer
Current Cancer Drug Targets Novel Pentablock Copolymer Based Nanoparticles Containing Pazopanib: A Potential Therapy for Ocular Neovascularization
Recent Patents on Nanomedicine Strategies to Overcome Multi-Drug Resistance in Cancer Cells: the Contribution of siRNA and Nanotechnologies
Current Organic Chemistry